CCM
NVS icon

Compass Capital Management’s Novartis NVS Stock Holding History

Compass Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-372,621
Closed -$25.2M – 44
2018
Q2 		$25.2M Buy
372,621
+32,318
+9% +$2.23M 3.67% 21
2018
Q1 		$24.7M Buy
340,303
+12,680
+4% +$965K 3.69% 19
2017
Q4 		$24.6M Buy
327,623
+10,860
+3% +$819K 3.73% 20
2017
Q3 		$24.4M Buy
316,763
+1,460
+0.5% +$110K 3.87% 14
2017
Q2 		$23.6M Buy
315,303
+3,358
+1% +$238K 3.84% 18
2017
Q1 		$20.8M Buy
311,945
+8,911
+3% +$594K 3.57% 23
2016
Q4 		$19.8M Buy
303,034
+23,236
+8% +$1.51M 3.69% 21
2016
Q3 		$19.8M Buy
279,798
+3,926
+1% +$286K 3.72% 19
2016
Q2 		$20.4M Buy
275,872
+36,655
+15% +$2.53M 3.9% 12
2016
Q1 		$15.5M Buy
239,217
+17,043
+8% +$1.16M 3.09% 25
2015
Q4 		$17.1M Buy
222,174
+10,696
+5% +$850K 3.63% 20
2015
Q3 		$17.4M Buy
211,478
+1,217
+0.6% +$108K 3.91% 13
2015
Q2 		$18.5M Sell
210,261
-2,095
-1% -$192K 3.91% 14
2015
Q1 		$18.8M Buy
212,356
+2,769
+1% +$246K 3.91% 11
2014
Q4 		$17.4M Sell
209,587
-972
-0.5% -$80.6K 3.72% 16
2014
Q3 		$17.8M Sell
210,559
-744
-0.4% -$60.2K 3.42% 7
2014
Q2 		$17.1M Sell
211,303
-4,217
-2% -$332K 3.32% 9
2014
Q1 		$16.4M Buy
215,520
+2,093
+1% +$153K 3.28% 12
2013
Q4 		$15.4M Buy
213,427
+3,399
+2% +$236K 3.1% 18
2013
Q3 		$14.4M Buy
210,028
+4,527
+2% +$300K 3.25% 11
2013
Q2 		$13M Buy
+205,501
New +$13.4M 3.17% 14

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Compass Capital Management's NVS Position: Q3 2018 in Review

Compass Capital Management sold out of Novartis (NVS) in Q3 2018, closing a stake of 372,621 shares — an estimated $25.2M sold.

Compass Capital Management first reported a position in NVS in Q2 2013 and held it in 21 quarters. The position peaked at $25.2M in Q2 2018. 1,029 funds tracked by Wall St. Rank hold NVS as of Q3 2018.

  • Compass Capital Management reported no remaining Novartis position as of Q3 2018 after selling out during the quarter.
  • Compass Capital Management sold 372,621 Novartis shares in Q3 2018, an estimated $25.2M.
  • Compass Capital Management first reported a position in Novartis in Q2 2013 and held it in 21 quarters.
  • Compass Capital Management's Novartis position peaked at $25.2M in Q2 2018.
  • 1,029 funds tracked by Wall St. Rank held Novartis as of Q3 2018.

Based on Compass Capital Management's 13F filing for Q3 2018, filed 31 Oct 2018.